CD200 as a prognostic factor in acute myeloid leukaemia
暂无分享,去创建一个
R. Hills | K. Mills | A. Burnett | R. Darley | A. Tonks | P. White | B. Rosie | Paul Charles White | R. Hills | K. I. Mills | A. K. Burnett
[1] T. Rème,et al. CD200 is a new prognostic factor in multiple myeloma. , 2006, Blood.
[2] J. Liu,et al. A role for the immunomodulatory molecules CD200 and CD200R in regulating bone formation. , 2006, Immunology letters.
[3] A. Saven,et al. Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] Joseph H. Phillips,et al. Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200 1 , 2003, The Journal of Immunology.
[5] Jiang Hu,et al. Anti-CD200R ameliorates collagen-induced arthritis in mice. , 2002, Clinical immunology.
[6] A. Barclay,et al. CD200 and membrane protein interactions in the control of myeloid cells. , 2002, Trends in immunology.
[7] B. Blom,et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). , 2000, Science.
[8] A. Barclay,et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. , 2000, Immunity.
[9] L. Cantley,et al. The Phosphotyrosine Interaction Domain of SHC Recognizes Tyrosine-phosphorylated NPXY Motif (*) , 1995, The Journal of Biological Chemistry.